CompletedPhase 2

A Study of Herceptin (Trastuzumab)and Biomarkers in Patients With HER2-Positive Metastatic Breast Cancer

NCT00885755

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

Royal Prince Alfred Hospital; Medical Oncology

Camperdown, New South Wales, Australia

+12 additional locations

Save this trial

Royal Prince Alfred Hospital; Medical OncologyCamperdown, New South Wales, Australia
Royal North Shore Hospital; OncologySt Leonards, New South Wales, Australia
Eastern Health Breast Cancer ResearchEast Ringwood, Victoria, Australia
Border Medical Oncology; Murray Valley Private HospitalWodonga, Victoria, Australia
Mount Medical CenterPerth, Western Australia, Australia
Royal Perth Hospital; Department of Medical OncologyPerth, Western Australia, Australia
Hospital Universitario Marques de Valdecilla; Servicio de OncologiaSantander, Cantabria, Spain
Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologiaValencia, Spain
Karolinska Hospital; Oncology - RadiumhemmetStockholm, Sweden
Akademiska sjukhuset, OnkologklinikenUppsala, Sweden
Hull Royal InfirmaryHull, United Kingdom
Christie Hospital; Breast Cancer Research OfficeManchester, United Kingdom
Nottingham City Hospital; OncologyNottingham, United Kingdom